A multi-disciplinary, “One Health” approach to cancer research is necessary to guide society in reduction of toxic substances, as well as regulation of chemical impacts on the environment and public health, according to an editorial published...
6-Jul-2022 5:05 PM EDT Add to Favorites
Oncology researchers using Virtual Reality (VR) in the treatment of cancer patients have published a review of the existing literature regarding the application of this technology for the rehabilitation of cancer survivors.
6-Jul-2022 3:45 PM EDT Add to Favorites
A group of researchers have identified potential novel drug candidates for the treatment of Malignant Pleural Mesothelioma (MPM).
28-Jun-2022 9:00 AM EDT Add to Favorites
Treatment with Cell Cycle Inhibitors: Another Caveat on a Clinical Trial for Mesothelioma Red-Flagged in Lancet Oncology
There is a growing awareness that the design of clinical trials can be misleading and provide evidence that does not end up actually benefiting patients in the clinical setting.
27-Jun-2022 3:00 PM EDT Add to Favorites
Public Health conference hosted by Temple University Rome and Temple College of Public Health.
9-May-2022 1:30 PM EDT Add to Favorites
The presence of Cervical Cancer Stem Cells (CCSCs) in cases of Cervical Cancer (CC) represent a small subpopulation of tumor cells with a high potential for resistance to conventional treatments.
6-May-2022 10:35 AM EDT Add to Favorites
Malignant Pleural Mesothelioma (MPM) is an aggressive cancer mostly related to asbestos exposure whose incidence is constantly rising, especially in low-income countries.
10-Mar-2022 6:05 AM EST Add to Favorites
Recently approved drugs to boost the immune response against cancer represents a novelty that should not be over-hyped, researchers say
27-Dec-2021 5:05 PM EST Add to Favorites
See All News
2-Mar-2021 8:15 AM EST
3-Nov-2020 2:35 PM EST
4-Jun-2020 9:55 AM EDT
COVID-19 is similar in symptoms to the seasonal flu, but to recognize it there is a different procedure and we have to act accordingly
6-Mar-2020 8:20 AM EST
16-Jan-2018 11:05 AM EST
Cancer expert Antonio Giordano, MD, PhD, Director of the Sbarro Institute for Cancer Research and Molecular Medicine at Temple University, describes the recent progress and future possibilities of treating SCLC.
13-Apr-2017 7:05 AM EDT
“Every cancer diagnosis should come with a referral to genetic counseling,” says cancer expert Dr. Antonio Giordano, President of the Sbarro Health Research Organization at Temple University.
8-Feb-2017 10:30 AM EST